BioCentury
ARTICLE | Financial News

Hookipa raises EUR 20 million in B round

November 5, 2013 2:03 AM UTC

Vaccine play Hookipa Biotech AG (Vienna, Austria) raised EUR 20 million ($27 million) in a series B round led by existing investors Sofinnova Ventures and Forbion Capital Partners. New investors Boehringer Ingelheim Venture Fund; Takeda Ventures; and BioMedPartners also participated. Boehringer's Frank Kalkbrenner joined Hookipa's board. ...